Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials (2023)
Article in International Scientific Journal
Ferreira, JP; Saraiva, F; Sharma, A; Vasques Novoa, F; Angelico Goncalves, A; Leite, AR; Borges Canha, M; Carvalho, Davide; Packer, M; Zannad, F; Leite-Moreira AF; Neves, JS

Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial (2023)
Article in International Scientific Journal
Neves, JS; Vasques Nóvoa, F; Borges Canha, M; Leite, AR; Sharma, A; Carvalho, Davide; Packer, M; Zannad, F; Leite-Moreira AF; Ferreira, JP

Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials (2022)
Article in International Scientific Journal
Leite, AR; Angelico Goncalves, A; Vasques Novoa, F; Borges Canha, M; Leite-Moreira AF; Neves, JS; Ferreira, JP

Prediction of heart failure outcomes in patients with type 2 diabetes mellitus: Validation of the Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes ( TRS¿HF DM ) in patients in the ACCORD trial (2021)
Article in International Scientific Journal
Elharram, M; Ferreira, JP; Huynh, T; Ni, J; Giannetti, N; Verma, S; Zannad, F; Sharma, A